1Heo DS. Progress and limitations in cancer gene therapy[J]. Genet Med,2002,4(Suppl6) :52S. 被引量：1
2St George JA. Gene therapy progress and prospects adenoviral vectors[J]. Gene Ther,2003,10 : 1135. 被引量：1
3Marchisone C, Pfeffer U, Del GF, et al. progress towards gene therapy for cancer[J]. J Exp Clin Cancer Res,2000,19(3):261. 被引量：1
4Carroll JL,Nielsen LL,Pruett SB,et al. The role of natural killer cells in adenovirus-mediated p53 gene therapy[J]. Mol Cancer Ther,2001,1(1):49. 被引量：1
5Das S, EI-Deiry WS, Somasundaram K. Efficient growth inhibition of HPV16 E6 -expressing cells by an adenovious-expressing p53 homologue p73 beta[J]. Oncogene,2003,22(52):8394. 被引量：1
6Saito Y,Swanson X,Mhashilkar AM. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo[j]. Gene Ther,2003,10(23):1961. 被引量：1
7Gotoh A, Shirakawa T, Wada Y. The growth inhibitory effect of p21 adenovirus on and rogen dependent and-independent human prostate cancer cells[J]. BJU Int,2003,92(3):314. 被引量：1
8Willis AC,Chen X. The promise and obstacle of p53 as a cancer therapeutic agent [J]. Curr Mol Med, 2002,2(4):329. 被引量：1
10Lewis DL, Hagstrom JE, Loomis AG, et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice[J]. Nat Genet,2002,32(1):107. 被引量：1
二级参考文献18
1Zeis M,Siegel S,Wagner A,et al.Generation of cytotoxic responses in mice and human individuals against hematological malignancies hematological malignancies using survivin-RNA-transfected dendritic cells[J].Immunology,2003,170(11):5391 被引量：1
2Driscoll L,Linehan R,Clynes M.Survivin: role in normal cells and in pathological conditions[J].Curr Cancer Drug Targets,2003,3:131 被引量：1
3Hoffman WH,Biade S,Zilfou JT,et al.Transcriptional repression of the antiapoptotic survivin gene by wild type P53[J].Biol Chem,2002,277:3247 被引量：1
4Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosisi gene,survivin,expreesed in cancer and lymphoma[J].Nat Med,1997,3:917 被引量：1
5Bosch Z,Marnix L,Michael L,et al.Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity[J].Immunotherapy,2002,25:289 被引量：1
6Nestle FO,Alijagic S,Gillet M,et al.Vaccination of melanoma patiens with peptide or tumor lysate-plused dendritic cells[J].Nat Med,1998,4:328 被引量：1
7Schmitz M,Diestelkoetter P,Weigle B,et al.Generation of survivin-specific CD8+T effector cells by dendritic cells pulsed with protein or selected peptides[J].Cancer Res,2000,60:4845 被引量：1
8Anderson MH,Pedersen L,Jurgen C,et al.indentification of a cytotoxix T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients[J].Cancer Res,2000,61:869 被引量：1
9Martin K,Michael R,Verneris,et al.Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells[J].Immun Lett,2001,76(3):169 被引量：1
10Casti C,Dalerba P,Rivoltini L,et al.The apotosis inhibitor protein survivin induces tumors specific CD8+ and CD4+ T cells in colorectal patients[J].Cancer Res,2003,63:4507 被引量：1
3Puttiz J Z, Wieland S, Blum H E, et al. Antisense RNA complementary to hepatitis B Virus specifically inhibits viral rep lication[J]. Gastroenterology, 1998, 115(3):702-713. 被引量：1
4Weinberg MS, Ely A, Passman M, et al. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors. Oligonucleotides, 2007, 17(1): 104-112. 被引量：1
5ShlomaiA, Shaul Y. Inhibition of hepatitis B virus expression and rep lication by RNA interference[J]. Hepatology, 2003,37(4): 764-770. 被引量：1
